RACHEL PORTMAN

DLA PIPER LLP (US) · Washington, DC · registered since 2024

Registered · LDAActive

Send proposal →Contact →Claim this profile →

At a glance

Registered since

2024

Senate LDA system

Clients

last 3 years

Filings

2 agencies contacted

Activity

filings by quarter

Works on

Health Issues 14 Medicare/Medicaid 4 Defense 3 Education 3 Intelligence 3 Medical/Disease Research/Clinical Labs 2

Background

Government experience

Deputy Health Policy Director

Committee on Senate Health, Education, Labor and Pensions; Health Policy Assistant, Sen. Richard Burr; Intern, Rep. Robert Portman

Disclosed on LD-2 filings

Career

DLA PIPER LLP (US)

Washington, DC

2024 - present

Specific issues

Issues related to medical devices and healthcare policy.

Health Issues · 2024 Q3

Policies and proposals impacting higher education for public research universities. H.R. 9029/S. 4942, Labor-HHS-Education Appropriations, FY2025, provisions regarding Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern.

Education · 2024 Q3

General education on issues related to the Drug Enforcement Agency (DEA). Issues related to substance use addiction and treatment, including NIH/HHS funding levels. Issues related to access to addiction treatments, including telehealth.

Health Issues · 2024 Q3

Medicaid Re-Entry Act, policies related to reimbursement of substance use disorder treatment and Mainstreaming Addiction Treatment Act.

Medicare/Medicaid · 2024 Q3

Legislative and regulatory proposals and policies regarding medical device innovation. H.R. 2369, Verifying Accurate, Leading-edge IVCT Development (VALID) Act of 2023. H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.

Medical/Disease Research/Clinical Labs · 2024 Q3

Medicare reimbursement, including the Medicare Physician Fee Schedule. Healthcare consolidation, including the Health Over Wealth Act (draft legislation).

Health Issues · 2024 Q3